[1] Zhu N, Zhang D, Wang W, et al.A novel coronavirus from patients with pneumonia in China, 2019[J]. N Engl J Med, 2020, 382(8):727-733. [2] Ralph R, Lew J, Zeng T S, et al.2019-nCoV (Wuhan virus), a novel Coronavirus:human-to-human transmission, travel-related cases, and vaccine readiness[J]. J Infect Dev Ctries, 2020, 14(1):3-17. [3] 中华人民共和国国家卫生健康委员会.关于印发新型冠状病毒肺炎诊疗方案(试行第6版)的通知(国卫办医函〔2020〕145号)[EB/OL]. [2020-02-19].http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. [4] Phelan AL, KatzR, GostinLO. The novel coronavirus originating in Wuhan, China:challenges for global health governance[J].JAMA, 2020, 323(8):709-710. [5] HuangC, WangY, LiX, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223):497-506. [6] 刘映霞, 杨扬, 张聪, 等.新型冠状病毒(2019-nCoV)感染患者肺损伤相关的临床及生化指标研究[J/OL].中国科学:生命科学:1-12[2020-03-11].http://kns.cnki.net/kcms/detail/11.5840.Q.20200212.0801.006.html. [7] 周玉平, 朱传新, 万禧伟, 等.咸宁地区3886例发热、咳嗽患者临床特征与实验室检查结果分析[J/OL].检验医学与临床: 1-9[2020-03-11].http://kns.cnki.net/kcms/detail/50.1167.R.20200304.1246.002.html. [8] Beswick EJ, Johnson JR, Saada JL, et al.TLR4activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+stromal cells[J].J Immunol, 2014, 193(5):2218-2229. [9] 朱名超, 朱娅.新型冠状病毒肺炎的实验室检查及临床实验室的管理[J/OL].热带医学杂志:1-4[2020-03-11]. [10] Benvenuto D, Giovanetti M, Ciccozzi A, et al.The 2019-new coronavirus epidemic:Evidence for virus evolution[J]. J Med Virol, 2020, 92(4):455-459. [11] He Z, Zhao C, Dong Q, etal. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets[J]. IntJInfectDis, 2005, 9(6):323-330. [12] 张益明, 高世定, 王占科, 等. 3例新型冠状病毒肺炎患者外周血CD4+T淋巴细胞和CD4+/CD8+比值变化[J/OL].国际检验医学杂志:1-7[2020-03-11].http://kns.cnki.net/kcms/detail/50.1176.R.20200306.0937.002.html. [13] 黄傲, 杨欣荣, 孙惠川, 等.新型冠状病毒肺炎相关肝损伤的发生机制及防治措施 [J/OL] .中华消化外科杂志, 2020, 19[2020-02-24]. http://rs.yiigle.com/yufabiao/1182664.htm. [14] 罗晶晶, 董念国, 史嘉玮. 新型冠状病毒感染相关心脏损害的机制探讨[J/OL]. 临床心血管病杂志:1-4[2020-03-10]. http://kns.cnki.net/kcms/detail/42.1130.r.20200309.1144.001.html [15] 陈实, 吴娟娟, 李志明, 等.新型冠状病毒肺炎109例临床分析 [J/OL] .中华传染病杂志, 2020, 38 [2020-02-27].http://rs.yiigle.com/yufabiao/1182759.htm. [16] 陈国伟, 肖素英, 苏文.不同病程甲型H1N1流感患者血清CK、CK-MB、AST、LDH水平变化及临床意义[J].现代医院, 2019, 19(6):921-923. [17] Mugosa B, Vujosevic D, Ciccozzi M, et al.Genetic diversity of thehaemagglutinin(HA)of human influenza A (H1N1) virus in Montenegro: Focus on its origin and evolution[J].J Med Virol, 2016, 88(11):1905-1913. [18] Ticinesi A, Lauretani F, Nouvenne A, et al.C-reactive protein(CRP)measurement in geriatric patients hospitalized for acute infection[ J].Eur J Intern Med, 2017, 37:7-12. |